Evidence map›Paper›PMID 36417213›Full record

ArticleEpidemiologia (Basel, Switzerland)2021

Control of Canine Visceral Leishmaniasis: A Success Case Based on Deltamethrin 4% Collars.

Vera Lucia Fonseca de Camargo-Neves, Eliana Bravo Calemes, Lilian Aparecida Colebrusco Rodas, Fredy Galvis-Ovallos, Luis Jacintho da Silva

Open access · goldAbstract read
In one paragraph

Article in Epidemiologia (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Investigation ofPathogens (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. Is leishmaniasis the new emerging zoonosis in the world?Veterinary research communications · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Vera Lucia Fonseca de Camargo-NevesEpidemiology Department, Superintendence for Endemic Diseases Control-Sucen, São Paulo 01027-000, Brazil.ORCID 0000-0001-8287-7727
Eliana Bravo CalemesRegional Laboratory Center, Adolfo Lutz Institute-IAL, Araçatuba 16015-160, Brazil.
Lilian Aparecida Colebrusco RodasAraçatuba Rgional Center, Superintendence for Endemic Diseases Control-Sucen, Araçatuba 16015-160, Brazil.
Fredy Galvis-OvallosEpidemiology Department, School of Health Public, University of São Paulo, São Paulo 01246-904, Brazil.
Luis Jacintho da SilvaEpidemiology Department, Superintendence for Endemic Diseases Control-Sucen, São Paulo 01027-000, Brazil.
Centro Universitario Toledo · BRInstituto Adolfo Lutz · BRUniversidade de São Paulo · BR

Funding

São Paulo Research Foundation 2017/50345-; 2014/50086-1
6 · The paper itself

Abstract

The effect of employing collars impregnated with deltamethrin 4% (DM4) to control canine visceral leishmaniasis (CVL) was evaluated. as were the individual factors associated with this infection. A cohort study that included household dogs was conducted between 2002 and 2006. The presence of pathognomonic signals, peridomiciliary sleep habits and breed were the main factors associated with the infection. The use of DM4 collars contributed to the reduction of CVL with an effectiveness of 66%, and the dogs' survival rate was greater than 90% at 50 months. In conclusion, the adoption of DM4 collars reduced the number of euthanized canines and in the incidence of CVL, and this reduction was sustained for one year after discontinuing the use of the collar.

Indexed as

associate factorscanine visceral leishmaniasiscollar impregnatedcontrol measureslogistic modelssurvival probability

Identifiers

PMID36417213
PMCPMC9620925
OpenAlexW3207448816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.